Search results
Heather Bresch (née Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn.
- 4
- Heather Kirby
- Businesswoman
- West Virginia University (BA)
Jul 29, 2019 · (Mylan) During Mylan CEO Heather Bresch's 28-year stint there, the company has utterly transformed into a generics giant—and courted controversy along the way. And now, Bresch says she's...
- Eric Sagonowsky
Sep 7, 2021 · Heather Bresch, the former president and CEO of the drugmaker Mylan, worked directly with the CEO of Pfizer to keep prices of the company’s EpiPen product artificially high, according to new...
- Ryan Grim
People also ask
Who is Heather Bresch?
Why is Heather Bresch stepping away from Mylan?
What happened to Mylan CEO Heather Bresch?
Did Mylan CEO Heather Bresch work with Pfizer?
Mar 17, 2022 · With a final hearing set for July, the deal puts Heather Bresch, Manchin’s daughter and Mylan’s former CEO, on track to dodge legal repercussion from a yearslong saga involving allegations of...
Nov 20, 2023 · Along with his daughter Heather Bresch, he has been soliciting funds for a new nonprofit that, according to documents reviewed by The Intercept, is being overseen by the senator’s longtime...
Heather Bresch is chief executive officer of Mylan, one of the largest generics and specialty pharmaceutical companies in the world. She also serves on the company’s board of directors. Mylan’s mission is to provide the world’s 7 billion people access to high quality medicine.
About Heather Bresch In May, Heather Bresch, CEO of the generic producer Mylan, projected annual sales as high as $11.5 billion, quite a jump from 2012's $6.1 billion, her first year.
